BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tolazoline

A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.

300+ PubMed studies analyzed · 7 RCTs · Evidence Score: 42.9

Research Domains

Tolazoline has been studied across 17 research domains including ❤️ Cardiovascular, 🫁 Respiratory, 🧠 Focus & Attention, 😴 Sleep, 🌤️ Mood & Depression. The primary research focus is ❤️ Cardiovascular with 24% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tolazoline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

brimonidine
6 shared targets
corynantheine
6 shared targets
Piperoxan
6 shared targets
Methoxamine
6 shared targets
Indoramin
7 shared targets
rauwolscine
6 shared targets
dexniguldipine
6 shared targets
terazosin
6 shared targets
clonidine
6 shared targets
Phenylephrine
6 shared targets
Loading evidence profile...

This evidence profile for Tolazoline is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.